PIC/S explores harmonized approach to classifying GMP deficiencies
This article was originally published in SRA
Executive Summary
The Pharmaceutical Inspection Convention and Co-operation Scheme is looking at possible approaches to harmonizing the classification of good manufacturing practice deficiencies and identify the most common GMP deficiencies noted during inspections1.
You may also be interested in...
PIC/S Guideline Sets Harmonized Approach For Classifying GMP Deficiencies Worldwide
PIC/S has issued guidance to help member pharmaceutical inspectorates classify good manufacturing practice deficiencies to ensure there is a consistent view across inspectorates as to which deficiencies are “critical” or “major.”
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.